The new use of recombinant adenovirus-p53 agent in treatment...

Details The new use of recombinant adenovirus-p53 agent in treatment... The new use of recombinant adenovirus-p53 agent in treatment...

C - Chemistry, Metallurgy

12

N

C12N 15/86 (2006.01) A61K 48/00 (2006.01) A61P 35/00 (2006.01) C12N 15/31 (2006.01)

Patent

CA 2595874

A recombined adenovirus p53 antagonizing the certain toxic side effects such as those caused by anti - tumor chemotherapy and radiotherapy. A single recombined adenovirus p53 can also enhance the body's function of tumor patient, including biochemical index, such as promote hemogram, liver function, kidney function and the like, and improve living quality, such as increase appetite, ameliorate mental status.

La présente invention a pour objet un adénovirus p53 recombiné qui annule certains effets secondaires toxiques tels que ceux causés par les chimiothérapies et les radiothérapies antitumorales. Le même adénovirus p53 recombiné peut également stimuler les fonctions physiologiques d'un patient atteint d'une tumeur, y compris les indicateurs biochimiques tels que l'hémogramme, le fonctionnement du foie, le fonctionnement des reins et similaires, et améliorer la qualité de vie, y compris en augmentant l'appétit et en améliorant l'humeur.

Affiliated with

Also associated with

Rating

The new use of recombinant adenovirus-p53 agent in treatment... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with The new use of recombinant adenovirus-p53 agent in treatment..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and The new use of recombinant adenovirus-p53 agent in treatment... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1527251